TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Tarsus Pharmaceuticals (NASDAQ:TARS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Tarsus Pharmaceuticals (NASDAQ:TARS) was given a new $100.00 price target on by analysts at Barclays PLC.
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? [Yahoo! Finance]
Tarsus to Participate in Upcoming Investor Conference
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 [Seeking Alpha]
Form 4 Tarsus Pharmaceuticals, For: Dec 16 Filed by: Whitfield Dianne C.
Form 4 Tarsus Pharmaceuticals, For: Dec 16 Filed by: Neervannan Seshadri
Form 4 Tarsus Pharmaceuticals, For: Dec 15 Filed by: LINK WILLIAM J PHD
Form 4 Tarsus Pharmaceuticals, For: Dec 15 Filed by: Lin Elizabeth Yeu
Form 144 Tarsus Pharmaceuticals, Filed by: Lin Elizabeth Yeu
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.